INNOVACAPPharmaceuticals
Innova Captab Ltd — PE Ratio & Valuation Analysis
₹689.85
-5.65%
Current P/E32.89xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E45.8x28.2% below avg
⚠️
3.5% Premium to Industry
INNOVACAP P/E 32.89x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹22.41 | ₹720 | 32.1x |
| 2024 | ₹18.66 | ₹1115 | 59.8x |
| 2023 | ₹11.87 | ₹541 | 45.6x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Innova Captab Ltd Valuation
Innova Captab Ltd (INNOVACAP) currently trades at 32.89x earnings. The Pharmaceuticals sector average PE is 31.77x. INNOVACAP commands a premium, reflecting high growth expectations. Historically, INNOVACAP has traded at an average PE of 45.8x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
14.34%
Dividend Yield
0.00%
More on Innova Captab Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.